3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
5
Phase 2/3
2
Phase EARLY_PHASE1
1
Phase 4
1
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Prostatic Neoplasms
1
Primary Dysautonomias
1
Kidney Diseases
1
Hypertension
1
Interventions
Dexamethasone
12
Bevacizumab
9
Saline Solution
8
Bupivacaine
8
Tobacco Use Cessation Devices
7
Specimen Handling
7
Nivolumab
7
Magnetic Resonance Spectroscopy
7
Rituximab
6
Prednisone
6
Letrozole
6
Lenalidomide
6
Fluorouracil
6
Cisplatin
6
Carboplatin
6
pembrolizumab
5
Sodium Chloride
5
Ropivacaine
5
Human Papillomavirus Recombinant Vaccine nonavalent
5
Trastuzumab
4
Tamoxifen
4
Standard of Care
4
Propofol
4
Paclitaxel
4
Immune Checkpoint Inhibitors
4
Esomeprazole
4
Enoxaparin
4
Doxorubicin
4
Bortezomib
4
Bismuth
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 4
×
Flutamide
×
1 year
×
Clear all
NCT05700903
2026-03-02
ARCH
University of Colorado, Denver
Phase 4
Completed
10 enrolled